Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up

Joost H. van den Berg, John B.A.G. Haanen, Remko Schotte et al.|Journal for ImmunoTherapy of Cancer|2020

Cited by 196